TRIB
Trinity BiotechDNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
Current thesis
If CGM+ milestones become dated and credible while the post-restructuring diagnostics base stays cash generative, TRIB’s tiny market cap leaves room for outsized upside on proof-of-execution.
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
2024 Form 20-F shows continued losses, thin cash relative to liabilities, and negative equity.
Momentum
64
Value
36
Sentiment
34
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.60 · Bull $1.10 · Bear $0.30
Data freshness
Prices
As of 2026-06-03
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-03 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-03
Investment thesis
As of 2026-06-03
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Why
Momentum64 · Δ7d -
Value36 · Δ7d -0.0
Sentiment34 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
64
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
34
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 63.9 / Value 36.3 / Sentiment 33.9
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$14.16M
Beta
0.62
Shares Out
385.2M
P/E (TTM) · Derived
-0.0
P/S (TTM)
0.29
P/FCF (TTM) · Derived
-0.04
Rev YoY
+18.1%
EPS YoY
-29.3%
Gross Margin
+33.8%
Op Margin
-48.8%
Net Debt
$95.6M
Current Ratio
1.05
As of 2026-06-03 • Updated nightlySource: Internal modelMethodology